Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 18, 2018 - AvKARE announced a voluntary recall of valsartan/hydrochlorothiazide (HCTZ) tablets due to an impurity, N-nitrosodimethylamine (NDMA).
Download PDF
Return to publications
